Solutions for Treatment-Resistant Depression
Around one in 13 people struggle with treatment-resistant depression and 30 percent will not respond to typical treatment approaches. Ozark Center now offers every available treatment option for treatment-resistant depression, and there is no need to seek care outside this area.
If you suffer from major depression, have tried two or more medications without success and are ready for long-term, sustainable relief and a better life, you’re in the right place.
“PRISM” stands for Psychiatric Renewal Through Innovative Solutions and Methods. We’re proud to offer pioneering, innovative approaches to treating clients with major complicated and/or treatment-resistant depression. PRISM is the first facility of its type found anywhere in the state of Missouri.
PRISM offers procedures that go beyond standard medication management by offering several FDA-approved treatment options. Each is recognized by behavioral health professionals for high success rates among patients for whom previous treatment options have been unsuccessful. Most patients experience at least a 50 percent reduction in depression symptoms and a third achieve remission of symptoms.
PRISM allows physicians a simple referral process to access additional support for their high-risk patients suffering from major depression.
SPRAVATO® nasal spray (esketamine)
SPRAVATO is the first FDA-approved nasal spray specifically for adults with treatment-resistant depression. Available with a prescription, SPRAVATO is used along with an oral antidepressant to treat treatment-resistant depression, as well as major depressive disorder with suicidal thoughts or actions. SPRAVATO® has an 87 percent success rate when used by itself or with other medications, and Ozark Center was the first facility in Missouri to offer it.
Transcranial Magnetic Stimulation (TMS)
TMS, also used to treat depression, utilizes a highly targeted pulsed magnetic eld, similar in type and strength to that produced by an MRI machine. TMS stimulates nerves in the part of the brain thought to control mood, making long-term remission from severe depression possible.
Electroconvulsive Therapy (ECT)
Electroconvulsive Therapy (ECT) is a safe, effective medical treatment for severe mental illnesses, especially treatment-resistant depression, bipolar disorder, and catatonia, where brief, controlled electrical currents induce a seizure to rapidly improve brain chemistry and symptoms, often when medications and therapy fail.
Advantages for providers and Ozark Center clients include:
- Expedited care, meaning patients are contacted and scheduled within 72 hours and will no longer need to wait for months to experience relief;
- Fast, simple referrals that simplify coordination of care between PRISM clients and their primary care providers; and
- Prompt, consistent follow-up (by PRISM’s staff) with the client’s primary care provider is a top priority.
- Long-term, sustainable relief from depression and anxiety – and a better life.
What’s Next? The first step is a referral from a primary care provider or behavioral health provider. Talk to your provider today about your depression symptoms, what medications you’ve tried for dealing with depression.
There is no longer a need to seek treatment for treatment-resistant depression outside our area. Please contact us to learn more about how we can help you position your patients for relief.